NCT05636774View on ClinicalTrials.gov

Empower the Heart of Patients With Terminal Cancer Using Cardiac Medicines Trial

NACompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

December 12, 2022

Primary Completion Date

January 31, 2025

Study Completion Date

March 1, 2025

Conditions
Patients With Advanced Cancer Receiving Specialized Palliative Care
Interventions
DRUG

Heart failure medication

Combination of Sacubitril/valsartan, Ivabradine, Ferric carboxymaltose and/or Empagliflozin.

DRUG

Placebo

Placebo tables / infusion

Trial Locations (1)

45147

University Hospital Essen, Essen

All Listed Sponsors
collaborator

Charite University, Berlin, Germany

OTHER

collaborator

Universitätsklinikum Leipzig

OTHER

collaborator

University Hospital Heidelberg

OTHER

collaborator

University Hospital Homburg/Saar

UNKNOWN

lead

University Hospital, Essen

OTHER